TP53 and cancer: - Mutation of BCL2- Overexpression of other anti-apoptotic proteins in the BCL2 family- Genetic alterations including TP53 and 1q23 amplification- Activation of signaling pathways including NF-κB and PI3K-AKT pathway- Clonal evolution- Dysregulation of cancer signaling pathways